Dr. E. (Elisa) Giovannetti (MD PhD)

Login as E. (Elisa) Giovannetti

• activity
• cancer
• cell
• cells
• expression
• growth
• liver
• lung
• membrane
• patients
• plasma
• receptor
• resistance
• signaling

Active as

Publications

(the most recent at the top)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9

Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma

Rigosertib elicits potent anti-tumor responses in colorectal cancer by inhibiting Ras signaling pathway

The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response-Letter

Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs

All publications..

Current research

(the most recent research is at the top)
Researcher	Activity of Novel Irreversible Inhibitors of Epidermal Growth Factor Receptor in Non Small Cell Lung Cancer
Researcher	New Molecular and pharmacological approaches against pancreatic cancer
Project leader	Molecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A (DZNeP) with gemcitabine in pancreatic cancer cells
Project leader	Genetic and molecular mechanisms underlying Pancreatic Ductal Adenocarcinoma aggressive behaviour and chemoresistance

Completed research projects

(the most recent research is at the top)
Project leader	A combination of advanced tumour models and array techniques for an effective treatment of pancreas carcinoma

Classification

D23120	Oncology